PD98059 Is an Equipotent Antagonist of the Aryl Hydrocarbon Receptor and Inhibitor of Mitogen-Activated Protein Kinase Kinase
- 1 March 1998
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 53 (3) , 438-445
- https://doi.org/10.1124/mol.53.3.438
Abstract
PD98059 [2-(2′-amino-3′-methoxyphenyl)-oxanaphthalen-4-one] is a flavonoid and a potent inhibitor of mitogen-activated protein kinase kinase (MEK). Concentrations of PD98059 of ≤20 μm were not cytotoxic to cultures of the immortalized human breast epithelial cell line MCF10A. The agent was weakly cytostatic at concentrations of ≥10 μm. In vivo exposure of cultures to ≤20 μm PD98059 for 2–22 hr did not affect overall extracellular signal-regulated kinase contents; however, exposure to PD98059 resulted in a rapid loss (>95%) of the dually phosphorylated forms of extracellular signal-regulated kinase (IC50 = 1 μm). Treatment of cultures with PD98059 of ≥1 μm either at the time of addition or up to 48 hr before the addition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppressed in a concentration-dependent manner the accumulation of induced steady state CYP1A1, CYP1B1, and NQO1 mRNAs. The addition of PD98059 to rat liver cytosol just before the addition of TCDD suppressed TCDD binding (IC50 = 4 μm) and aryl hydrocarbon receptor (AHR) transformation (IC50 = 1 μm), as measured by sucrose gradient centrifugation and electrophoretic mobility shift assays. Flavone and flavanone, two closely related structural analogs of PD98059, inhibited AHR transformation by TCDD with IC50 values similar to that obtained with PD98059. However, neither analog was as potent as PD98059 in inhibiting MEK (IC50 ∼ 190 μm for both). These results suggest that PD98059 is a ligand for the AHR and functions as an AHR antagonist at concentrations commonly used to inhibit MEK and signaling processes that entail MEK activation.Keywords
This publication has 42 references indexed in Scilit:
- Complementation of Ah Receptor Deficiency in Hepatoma Cells: Negative Feedback Regulation and Cell Cycle Control by the Ah ReceptorExperimental Cell Research, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- The Aryl Hydrocarbon Receptor ComplexAnnual Review of Pharmacology and Toxicology, 1995
- Parallel signal processing among mammalian MAPKsTrends in Biochemical Sciences, 1995
- Phorbol ester - mediated suppression of cytochrome P450 Cyp1a-1 induction in murine skin: Involvement of protein kinase CBiochemical and Biophysical Research Communications, 1992
- Regulation of surface‐differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c‐Ha‐ras proto‐oncogeneInternational Journal of Cancer, 1992
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991
- Distribution of catalase and its modulation by 12-O-tetradecanoylphorbol-13-acetate in murine dermis and subpopulations of keratinocytes differing in their stages of differentiationCarcinogenesis: Integrative Cancer Research, 1988
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970